Cargando…
Magnesium sulfate reduces the rocuronium dose needed for satisfactory double lumen tube placement conditions in patients with myasthenia gravis
BACKGROUND: Using a minimum dose of neuromuscular blockade (NMB) to achieve intubation condition is one of the goals in anaesthesia management of patients with myasthenia gravis (MG) for thoracoscopic (VATS) thymectomy. However, tracheal intubation with double lumen tube (DLT) could be challenging i...
Autores principales: | Fei, Shoujun, Xia, Hengfu, Chen, Xiaowei, Pang, Dazhi, Xu, Xuebing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717642/ https://www.ncbi.nlm.nih.gov/pubmed/31472669 http://dx.doi.org/10.1186/s12871-019-0841-4 |
Ejemplares similares
-
Extreme Paralysis Following Rocuronium Administration in a Myasthenia Gravis Patient: A Case Report
por: Billups, Kelsey, et al.
Publicado: (2023) -
Efficacy of magnesium sulfate as an adjuvant to rocuronium in general anaesthesia: a meta-analysis
por: Sun, Haiyan, et al.
Publicado: (2021) -
Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007) -
Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011) -
Myasthenia Gravis
Publicado: (1905)